Proxygen
Entity

  • Proxygen

    Created in 2020
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    486 3,528

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Siemensstraße 89, 1210 Wien, Austria

    Wien

    Austria

  • Employees

    Scale: 11-50

    Estimated: 37

  • Engaged corporates

    1
    0 0

  • Added in Motherbase

    1 year, 6 months ago
Description
  • Value proposition

    The Art of Glue Hunting

    A curious team of explorers, deeply rooted in science, and constantly on the lookout for a very particular novel drug modality. This is us – Proxygen. We hunt for glue degraders. They are the key to unlocking new treatments for patients. They revolutionize how we see and cure diseases.

  • Proxygen

    Proxygen hunts for molecular glue degraders because they solve the biggest challenge of drug discovery: disease-driving proteins that are difficult – or impossible – to drug.

    • https://proxygen.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Merck Group
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing 		Other

3 Jun 2022


Similar entities
Last news
Show all articles
Social network dynamics